Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients

Graefes Arch Clin Exp Ophthalmol. 2019 Feb;257(2):427. doi: 10.1007/s00417-018-4152-0. Epub 2018 Sep 24.

Authors

Cyril Meillon¹, Pierre Henri Gabrielle¹, Alain M Bron², Catherine Creuzot-Garcher¹

Affiliations

¹ Department of Ophthalmology, University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.
² Department of Ophthalmology, University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France. [email protected].

PMID: 30251200
DOI: 10.1007/s00417-018-4152-0

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants / adverse effects*
Anticoagulants / therapeutic use
Humans
Multicenter Studies as Topic*
Platelet Aggregation Inhibitors / adverse effects*
Platelet Aggregation Inhibitors / therapeutic use
Prospective Studies
Retinal Diseases / surgery*
Vitreoretinal Surgery / methods*

Substances

Anticoagulants
Platelet Aggregation Inhibitors